stoxline Quote Chart Rank Option Currency Glossary
  
Elevance Health Inc. (ELV)
376.53  -8.02 (-2.09%)    06-16 16:00
Open: 384.88
High: 383.18
Volume: 1,393,682
  
Pre. Close: 384.55
Low: 371.65
Market Cap: 85,071(M)
Technical analysis
2025-06-16 4:37:11 PM
Short term     
Mid term     
Targets 6-month :  465.71 1-year :  495.51
Resists First :  398.72 Second :  424.23
Pivot price 382.27
Supports First :  357.45 Second :  297.39
MAs MA(5) :  382.42 MA(20) :  385.36
MA(100) :  406.3 MA(250) :  445.12
MACD MACD :  -5.8 Signal :  -6.7
%K %D K(14,3) :  49.3 D(3) :  45.9
RSI RSI(14): 41.4
52-week High :  567.26 Low :  357.45
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ELV ] has closed above bottom band by 20.2%. Bollinger Bands are 47.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 385.62 - 387.81 387.81 - 390.19
Low: 365.58 - 367.98 367.98 - 370.58
Close: 371.97 - 376.17 376.17 - 380.74
Company Description

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Headline News

Mon, 16 Jun 2025
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel ... - Eagle-Tribune

Mon, 16 Jun 2025
ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for - GlobeNewswire

Mon, 16 Jun 2025
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - WV News

Mon, 16 Jun 2025
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV - PR Newswire

Mon, 16 Jun 2025
INVESTOR ALERT: Berger Montague Advises Elevance Health (ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - TradingView

Mon, 16 Jun 2025
ELV Lead Plaintiff Deadline Approaching - Robbins LLP Reminds Investors to Get Information About Leading the Class Action Against Elevance Health, Inc. - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 226 (M)
Shares Float 225 (M)
Held by Insiders 0.1 (%)
Held by Institutions 93 (%)
Shares Short 2,610 (K)
Shares Short P.Month 3,060 (K)
Stock Financials
EPS 25.69
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 188.36
Profit Margin 3.2 %
Operating Margin 6.4 %
Return on Assets (ttm) 4.9 %
Return on Equity (ttm) 14.1 %
Qtrly Rev. Growth 14.8 %
Gross Profit (p.s.) 224.79
Sales Per Share 810.48
EBITDA (p.s.) 43.5
Qtrly Earnings Growth 0.2 %
Operating Cash Flow 4,850 (M)
Levered Free Cash Flow 7,440 (M)
Stock Valuations
PE Ratio 14.65
PEG Ratio 0
Price to Book value 1.99
Price to Sales 0.46
Price to Cash Flow 17.54
Stock Dividends
Dividend 1.71
Forward Dividend 0
Dividend Yield 0.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android